Educational Messages for Cardiovascular Disease
(CONNECT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The CONNECT: "Developing a learning COmmunity to increase eNgagemeNt and Enrollment in cardiovascular Clinical Trials" is comprehensive, participant-centered learning platform designed to increase diversity in cardiovascular disease research among women and Black and Latino adults. CONNECT will deploy electronic health record (EHR)-informed and community-engaged recruitment approaches to identify and recruit adults with cardiovascular disease or a cardiovascular disease risk factor to join CONNECT. Participants who join CONNECT will receive tailored educational information on cardiovascular health and research participation via text message. Participants will also have the opportunity to be connected to ongoing cardiovascular research studies based on basic demographic information and areas of interest. The educational information will be sent to participants for 12 months. The CONNECT platform will be used to evaluate recruitment methods. The investigators hypothesize the proportion of women and Black and Latin adults enrolled in trials that partner with CONNECT will be higher following the use of CONNECT for recruitment. Investigators also hypothesize that participating in CONNECT will increase participants' clinical trial awareness, trust, and willingness to participate in clinical trials.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is the treatment generally safe for humans?
Safety data for treatments can be limited when they first become available, but additional information is gathered over time through reports and studies. For example, safety advisories have been issued for various drugs regarding heart-related risks, and monitoring patients is often recommended to ensure safety.12345
How does the educational message treatment for cardiovascular disease differ from other treatments?
This treatment is unique because it focuses on delivering educational messages through mobile phones to help patients with coronary artery disease understand and manage their condition better. Unlike traditional treatments that may focus on medication or procedures, this approach emphasizes patient education and engagement through digital communication, which can be personalized and ongoing.678910
What data supports the effectiveness of the treatment CONNECT for cardiovascular disease?
Who Is on the Research Team?
Hailey N Miller, PhD, RN
Principal Investigator
Johns Hopkins School of Nursing
Cheryl R Dennison Himmelfarb, PhD, RN, ANP
Principal Investigator
Johns Hopkins School of Nursing
Are You a Good Fit for This Trial?
The CONNECT trial is for US residents aged 18 or older who can read English or Spanish, self-identify with cardiovascular disease or risk factors like Type 2 Diabetes, obesity, high blood pressure, stroke, and high cholesterol. They must own a mobile phone and be open to receiving text messages.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Recruitment and Enrollment
Participants are recruited using EHR-informed and community-engaged approaches and enrolled into the CONNECT platform
Educational Intervention
Participants receive tailored educational text messages on cardiovascular health and research participation for 12 months
Follow-up
Participants are monitored for changes in clinical trial awareness, trust, and willingness to participate in trials
What Are the Treatments Tested in This Trial?
Interventions
- CONNECT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
American Heart Association
Collaborator
Morgan State University
Collaborator